{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:15:09Z","timestamp":1788466509929,"version":"build-2803163510"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transthyretin amyloid cardiomyopathy (ATTR-CM) coexists in up to 15% of elderly patients with severe aortic stenosis (AS), presenting complex diagnostic and therapeutic challenges due to overlapping clinical phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>An 85-year-old female presented with a 2-month history of heart failure and a previous medical history of total knee replacement. Echocardiography and computed tomography confirmed severe AS, alongside left ventricular hypertrophy out of proportion to the valvular load and an \u2018apical sparing\u2019 strain pattern. Due to the accompanying red flags, a Tc99m-PYP bone scintigraphy was done. This showed a Grade 3 cardiac uptake, and further testing confirmed wild-type ATTR-CM. Given her recent symptom onset, preserved ejection fraction, and high-gradient AS, the Heart Team prioritized transcatheter aortic valve implantation (TAVI). Following a successful procedure, she demonstrated excellent functional recovery at one month, which clinically justified the subsequent initiation of transthyretin stabilizers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Concomitant ATTR-CM must be suspected in elderly AS patients presenting with disproportionate hypertrophy or other clinical\/imaging \u2018red flags\u2019. A sequential management strategy\u2014prioritizing TAVI to relieve the haemodynamic bottleneck, followed by clinical reassessment\u2014can effectively identify appropriate candidates for long-term, disease-modifying transthyretin stabilizer therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag511","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:59:05Z","timestamp":1783598345000},"source":"Crossref","is-referenced-by-count":0,"title":["Challenges in diagnosis and management of severe aortic stenosis with coexisting cardiac amyloidosis: a case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-5509","authenticated-orcid":false,"given":"Rengin","family":"\u00c7etin G\u00fcven\u00e7","sequence":"first","affiliation":[{"name":"Department of Cardiology, Istanbul Okan University , Tepeoren District Tuzla Campus, 34959 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6738-266X","authenticated-orcid":false,"given":"Tolga Sinan","family":"G\u00fcven\u00e7","sequence":"additional","affiliation":[{"name":"Memorial Healthcare Group, Memorial G\u00f6ztepe Hospital , Karaman Street No. 1, 34634 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcsl\u00fcm","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Memorial Healthcare Group, Memorial G\u00f6ztepe Hospital , Karaman Street No. 1, 34634 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026090315233919400_ytag511-B1","doi-asserted-by":"crossref","DOI":"10.31083\/RCM28185","article-title":"Age differences in aortic stenosis","volume":"26","author":"Hamana","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"2026090315233919400_ytag511-B2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. The Troms\u00f8 study","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart"},{"key":"2026090315233919400_ytag511-B3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijcard.2014.08.053","article-title":"The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjav\u00edk study","volume":"176","author":"Danielsen","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026090315233919400_ytag511-B4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090315233919400_ytag511-B5","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis: JACC review topic of the week","volume":"74","author":"Ternacle","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026090315233919400_ytag511-B6","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur Heart J"},{"key":"2026090315233919400_ytag511-B7","article-title":"TTR amyloidosis: current state of affairs and promise for the future","volume":"10","author":"Brailovsky","year":"2023","journal-title":"JACC Case Rep"},{"key":"2026090315233919400_ytag511-B8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","author":"Yamamoto","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2026090315233919400_ytag511-B9","doi-asserted-by":"crossref","DOI":"10.1186\/1532-429X-14-50","article-title":"Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance","volume":"14","author":"Dweck","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090315233919400_ytag511-B10","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead106","article-title":"Cardiac amyloidosis and aortic stenosis: a state-of-the-art review","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2026090315233919400_ytag511-B11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.recesp.2025.01.018","article-title":"Impact of amyloidosis on outcomes after transcatheter aortic valve implantation","volume":"78","author":"Gerra","year":"2025","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026090315233919400_ytag511-B12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.acvd.2024.04.007","article-title":"Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: findings from the CAMPOS-TAVI study","volume":"117","author":"Costa","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"2026090315233919400_ytag511-B13","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026090315233919400_ytag511-B14","article-title":"Management of cardiac amyloidosis with concomitant left ventricular outflow tract obstruction","volume":"30","author":"Gupta","year":"2025","journal-title":"JACC Case Rep"},{"key":"2026090315233919400_ytag511-B15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026090315233919400_ytag511-B16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","article-title":"Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy","volume":"141","author":"Kazi","year":"2020","journal-title":"Circulation"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag511\/68754730\/ytag511.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/9\/ytag511\/68754730\/ytag511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/9\/ytag511\/68754730\/ytag511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:23:47Z","timestamp":1788463427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag511\/8731917"}},"subtitle":[],"editor":[{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Yanjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Kitaek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Dylan","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag511","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,10]]},"article-number":"ytag511"}}